Connor Clark & Lunn Investment Management Ltd. acquired a new stake in Addus HomeCare Corporation (NASDAQ:ADUS – Free Report) in the 2nd quarter, according to the company in its most recent filing with the SEC. The fund acquired 28,856 shares of the company’s stock, valued at approximately $2,899,000.
A number of other institutional investors also recently modified their holdings of ADUS. Global Retirement Partners LLC raised its holdings in shares of Addus HomeCare by 395.7% during the fourth quarter. Global Retirement Partners LLC now owns 233 shares of the company’s stock valued at $25,000 after purchasing an additional 186 shares during the period. Larson Financial Group LLC grew its stake in Addus HomeCare by 133.3% in the third quarter. Larson Financial Group LLC now owns 238 shares of the company’s stock valued at $28,000 after acquiring an additional 136 shares during the period. NFJ Investment Group LLC bought a new stake in shares of Addus HomeCare during the second quarter valued at approximately $29,000. Acumen Wealth Advisors LLC bought a new stake in shares of Addus HomeCare during the fourth quarter valued at approximately $29,000. Finally, Arax Advisory Partners raised its position in shares of Addus HomeCare by 95.8% during the fourth quarter. Arax Advisory Partners now owns 280 shares of the company’s stock worth $30,000 after purchasing an additional 137 shares during the period. Institutional investors and hedge funds own 95.35% of the company’s stock.
Wall Street Analyst Weigh In
A number of analysts have commented on ADUS shares. Royal Bank Of Canada boosted their price target on shares of Addus HomeCare from $130.00 to $134.00 and gave the company an “outperform” rating in a research note on Wednesday, August 5th. Barclays lifted their price objective on shares of Addus HomeCare from $92.00 to $96.00 and gave the company an “underweight” rating in a report on Wednesday, July 8th. Citigroup reissued a “market outperform” rating on shares of Addus HomeCare in a research report on Friday, July 24th. Citizens Jmp reissued a “market outperform” rating and issued a $142.00 price objective on shares of Addus HomeCare in a research note on Monday, May 18th. Finally, Weiss Ratings raised shares of Addus HomeCare from a “hold (c-)” rating to a “hold (c)” rating in a research report on Thursday, July 9th. One investment analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $130.88.
Insider Activity at Addus HomeCare
In other news, insider Heather Brianne Dixon sold 288 shares of Addus HomeCare stock in a transaction that occurred on Monday, June 22nd. The stock was sold at an average price of $93.77, for a total value of $27,005.76. Following the sale, the insider directly owned 44,371 shares in the company, valued at approximately $4,160,668.67. This trade represents a 0.64% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 4.10% of the stock is owned by corporate insiders.
Addus HomeCare Stock Performance
Shares of ADUS stock opened at $115.55 on Friday. The company has a debt-to-equity ratio of 0.05, a quick ratio of 1.69 and a current ratio of 1.69. The firm has a market cap of $2.16 billion, a price-to-earnings ratio of 20.27, a P/E/G ratio of 1.58 and a beta of 0.87. Addus HomeCare Corporation has a 52 week low of $87.95 and a 52 week high of $124.43. The firm’s 50-day simple moving average is $111.95 and its two-hundred day simple moving average is $102.96.
Addus HomeCare (NASDAQ:ADUS – Get Free Report) last released its earnings results on Monday, August 3rd. The company reported $1.73 earnings per share for the quarter, beating analysts’ consensus estimates of $1.70 by $0.03. The firm had revenue of $377.41 million during the quarter, compared to the consensus estimate of $376.24 million. Addus HomeCare had a net margin of 7.13% and a return on equity of 9.96%. The company’s revenue was up 8.0% compared to the same quarter last year. During the same period in the prior year, the firm earned $1.49 EPS. As a group, equities analysts forecast that Addus HomeCare Corporation will post 6.3 earnings per share for the current year.
About Addus HomeCare
Addus HomeCare (NASDAQ: ADUS) is a leading provider of home and community-based care services for elderly, disabled, and medically complex individuals across the United States. Through a network of company-owned and franchise locations, the company delivers a broad spectrum of non-medical personal care and licensed home health services designed to support clients’ independence and quality of life.
The company’s core offerings include personal care assistance—covering daily living activities, medication reminders, and light housekeeping—and skilled home health services delivered under the supervision of registered nurses and licensed therapists.
Featured Articles
- Five stocks we like better than Addus HomeCare
- 3 Financial Stocks Positioned for the Fed’s Next Move After Jackson Hole
- IREN’s AI Pivot Looks Real, But the Market Wanted a Faster Payoff After Earnings
- Boeing’s $131B F-15 Win: Mach 1 Momentum or Just Altitude?
- Okta Stock Surges 29%—Is $200 the Next Stop?
Want to see what other hedge funds are holding ADUS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Addus HomeCare Corporation (NASDAQ:ADUS – Free Report).
Receive News & Ratings for Addus HomeCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus HomeCare and related companies with MarketBeat.com's FREE daily email newsletter.
